Connect with us

Business

Justice Department could help marijuana industry via Cole Memo 2.0 – or hurt reform

Published

on

As federal marijuana reform inches forward in a Congress paralyzed by partisan gridlock, more immediate “progress” might have to come from the Biden administration.

U.S. Attorney General Merrick Garland’s Department of Justice might address the thorny issue of cannabis banking when his office revisits its approach toward the state-legal but federally prohibited marijuana industry, Washington insiders believe.

A friendly – or at least hands-off – Justice Department would be welcome news to marijuana businesses frustrated and exhausted with inaction in Congress, where bipartisan reform bills such as the SAFE Banking Act remain stalled.

However, a policy memo by itself, much like the landmark 2013 “Cole Memo,” is unlikely to convince more banks to offer basic services to marijuana businesses, several observers said.

And such a document – dubbed by some insiders as a Cole Memo 2.0 – could even backfire.

Pro-cannabis GOP lawmakers and the lobbyists attempting to win necessary conservative support for marijuana reform in Congress fear that unilateral action – though consistent with President Joe Biden’s MJ rescheduling review and low-level federal pardons – could turn off Congressional Republicans.

That, in turn, would make it more difficult to pass major reform legislation such as cannabis banking and removing marijuana from Schedule 1 of the Controlled Substances Act.

“I’m happy that both Congress and the administration are beginning to look more seriously at the need for federal cannabis reform,” U.S. Rep. Dave Joyce, an Ohio Republican and a lead sponsor of marijuana reform, told MJBizDaily.

“However, it would be most helpful if both branches worked in coordination as opposed to unilaterally.”

He added that lawmakers need “answers from the agencies and the agencies need more direction from” Congress.

Cole Memo 2.0

In 2013, a deputy attorney general in the Obama Justice Department named James Cole released a four-page policy advisory that’s been credited with allowing the state-legal marijuana industry as we know it to exist.

Crafted after voters approved adult-use legalization in Colorado and Washington but before the beginning of retail sales in those markets, the Cole Memo gave U.S. attorneys guidance for deciding how to deal with state-legal marijuana businesses in their districts.

Jeff Sessions, the first attorney general in the Trump Administration, rescinded the Cole Memo in January 2018.

But the Justice Department has not strayed from the memo’s general guidelines.

The Biden administration’s DOJ has been “examining marijuana policy” since at least last year, Garland said during a March 1 congressional oversight hearing.

“Within the department, we are still working on a marijuana policy” that “will be very close to what was done with the Cole Memorandum,” Garland told U.S. Sen. Cory Booker, a New Jersey Democrat who is a leading progressive voice for marijuana legalization in Washington DC.

Neither Booker nor the DOJ responded to MJBizDaily requests for comment.

It’s unclear when the DOJ might reevaluate its stance on the continuing conflict between federal drug laws and the legal medical and adult-use marijuana businesses operating in 39 states.

But several sources said they expect the Justice Department to move this year on so-called Cole Memo 2.0.

“We expect to see informal policy guidance in the form of a Cole 2.0 in the very near future here,” said Christian Sederberg, founding partner of Denver-based cannabis law firm Vicente.

The original Cole Memorandum identified eight tenets that state-legal marijuana businesses could follow in order to not become “priorities” for federal prosecution.

These included keeping cannabis away from minors, keeping marijuana sales revenue “from going to criminal enterprises, gangs and cartels” and stopping state-legal MJ from illegally crossing into other states.

At the time, the memo’s impact was profound.

States became confident they could legalize, regulate and tax adult-use marijuana without federal interference.

And entrepreneurs and investors could open and fund state-legal businesses with more clearly defined (and less) risk.

However, much has changed since then.

Friendlier White House

Adult-use marijuana is now legal in 21 states. Sales have begun in 19 of those states.

Companies operating in multiple states are listed on public stock exchanges in Canada and attracting investment from Fortune 500 legacy players such as tobacco giant Altria and garden-supply titan Scotts Miracle-Gro.

States continue to open individual marijuana markets – sales in Missouri began in January, while Maryland could follow this summer – as the DOJ stands by and watches.

Businesses once fearful of federal raids are now considering more complex questions around institutional investment and even exploring interstate commerce.

And at the same time federal drug enforcement seems uninterested in stymieing legal marijuana, a friendlier-than-ever White House is emerging.

In December, President Joe Biden signed a cannabis research bill into law after triggering an administrative review of marijuana’s status under the Controlled Substances Act.

The president also pardoned certain low-level marijuana offenders, and in a near-complete reversal, Biden, the lead sponsor of the 1994 Crime Bill, called the country’s war on marijuana a “failed approach.”

An updated Cole Memo would fit neatly into that pattern.

“The cannabis industry is mindful that now is the time to better describe how the industry works,” said David Mangone, director of policy at the National Cannabis Roundtable, a Washington DC-based lobbying shop.

“I think when the Cole Memo was written, you’d be hard-pressed to find someone in the Justice Department who had contemplated MSOs or companies listing on Canadian exchanges.”

“I would be shocked if the DOJ just reupped the language word for word from the Cole Memo,” Mangone added.

“We’re in a different place now.”

For those reasons, it’s likely that Garland’s directions will do more than merely restate the decade-old Cole Memo’s eight tenets.

And there is existing federal policy that addresses cannabis banking that could easily be rolled into any policy document.

In February 2014, the U.S. Treasury Department’s Financial Crimes Enforcement Network (FinCEN) issued its own guidelines for marijuana businesses.

The FinCEN guidelines told banks what “red flags” would trigger “suspicious activity report” filings to federal regulators.

Also in 2014, the DOJ’s Cole released another memo.

While it restated the August 2013 memo’s caveat that it was advisory and not binding, it also gave banks clear direction – noting “it is essential that financial institutions adhere to FinCEN’s guidance.”

The FinCEN guidelines’ provisions inform the SAFE Banking Act that passed the House of Representatives seven times before stalling out in the Senate, most recently in December when Senate leadership blocked the language from inclusion in two larger bills.

Thus, it would be an easy win for the Biden DOJ to fold both into an updated policy document, observers said.

“I think it would definitely be helpful to give even more clarity to banks that are considering” working with cannabis businesses, Vicente’s Sederberg said. “It could help them get around some of the concerns around risk.”

“It definitely would not hurt, and it would help.”

Unsafe behavior

Though some marijuana business interests would welcome a “new Cole Memo,” its long-term value is debatable.

It would not reschedule cannabis, and so it would not fix the marijuana industry’s ongoing headache over Section 280E of the IRS code, which prohibits businesses from deducting typical business expenses on their federal tax returns.

It’s also unlikely such a document would encourage more banks to serve cannabis businesses, according to Washington lobbies for both banks and marijuana interests.

“Banks, being much more risk averse than folks in the cannabis industry – or even state governments – are going to need much more than just a regurgitation of guidance from either (the) Treasury (Department) or DOJ,” said Morgan Fox, political director for NORML.

“They’re going to need to see something in law before they really start getting involved.”

Also, an “activist” Biden Justice Department could fuel more investigations from a GOP-controlled House of Representatives while also giving Republican senators pause if and when SAFE Banking is again introduced in the Senate.

It could also create what would amount to a false dawn.

Andrew Freedman, the executive director of the Coalition for Cannabis Policy, Education, and Regulation – a Washington DC-based lobby whose members include cannabis-involved liquor and tobacco conglomerates – called a new Cole Memo “a double-edged sword” that “could do more harm than good.”

It’s possible that some cannabis business interests overstated to their investors or to other interests when federal legalization might be coming.

For them, a DOJ memo might offer brief cover, Freedman said – but only in the short term.

“This is ultimately now just a question for Congress,” he said. “Everything else we do around the rescheduling debate just gives a lot of false hope.

“No matter what, that’s going to be a long haul.

“And I think things that detract from the sense of urgency that Congress has to act is not helpful.”

Source: https://mjbizdaily.com/justice-department-could-help-marijuana-industry-via-new-cole-memo/

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News